Overall rank by patents
#1,381
of 49,997 tracked assignees
USPTO PatentsView assignee record - 304 granted patents across 46 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).
The verdict
According to USPTO PatentsView, Pacific ranks #1,381 of 49,997 tracked US assignees by granted-patent volume, with 304 patents across 46 technology areas.
USPTO PatentsView assignee plate
Corpus R1381 · US Corporation #1,381 · 304 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Avent, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
AyDeeKay · near
62 score
Barco · near
62 score
Beijing Jiaotong… · near
62 score
Pacific Biosciences… · this assignee
62 score
Yaskawa Denki · near
62 score
3D Lighting… · lowest
7 score
What this shows Pacific's Innovation Score is 61.5/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Pacific Biosciences OF California, Inc. is a focused PatentsView assignee: 46 CPC subclasses with 85.2% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2015 (40 grants) versus a trough of 21 in 2022. By volume, Pacific sits between Yahoo Assets LLC and ELC Management LLC.
From 2019–2021 to 2022–2024, Pacific Biosciences OF California, Inc. moved from 86 to 71 grants (0.83x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,737. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Yahoo Assets LLC
305 patents
Yandex Europe AG
305 patents
Avent, Inc.
304 patents
Keyence Corporation
304 patents
STC.UNM
304 patents
Webasto SE
304 patents
Pacific Biosciences OF California, Inc.
304 patents
DeepMind Technologies Limited
303 patents
ELC Management LLC
303 patents
What this shows Pacific holds 304 patents at rank #1,381, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,381 in granted patent volume.
Other assignees with the most granted patents in Pacific's primary technology class.
Two PlainPatent-derived peer sets for Pacific, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (62 here).
Nearest assignees by average claims per patent (20.4 here).
Pacific's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
62 Top 3% higher than 97% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 40 | 13.2% |
| 2016 | 25 | 8.2% |
| 2017 | 39 | 12.8% |
| 2018 | 30 | 9.9% |
| 2019 | 24 | 7.9% |
| 2020 | 37 | 12.2% |
| 2021 | 25 | 8.2% |
| 2022 | 21 | 6.9% |
| 2023 | 24 | 7.9% |
| 2024 | 26 | 8.6% |
| 2025partial year | 13 | 4.3% |
Top 15 of 46 technology areas
Overall rank by patents
#1,381
of 49,997 tracked assignees
61.5 out of 100
What to do with this data
Pacific Biosciences OF California, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.